Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.
第一作者:
Maorong,Wang
第一单位:
Department of Endocrinology, West China Hospital, Sichuan University Chengdu 610041 Sichuan China 1100312222@vip.jiangnan.edu.cn yerongyu@scu.cn.;Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities Enshi 445000 Hubei China.
作者:
DOI
10.1039/d2ra90118h
PMID
36425214
发布时间
2022-11-25
- 浏览0
RSC advances
33348页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



